HTAI, HEALTH TECHNOLOGY ASSESSMENT MEETING, WORKSHOPS, ISGS, IJTAHC

POLICY FORUM, REGIONAL MEETINGS, BUILDING CAPPACITIES,GLOSSARY

Dr. Iñaki Gutiérrez Ibarluzea

Past Secretary of HTAi

Co-chair of the ISPC Tokyo HTAi 2016

HTAi, a global HTA society, current achievements and future initiatives

Health Technology Assessment

International (HTAi)

• Global scientific and professional society for those who produce, use, or

encounter HTA

• ≈1,300 members from approx. 65 countries

Includes 16 for-profit and 60 not-for-profit organizations

• Embraces all stakeholders, including researchers, agencies, policymakers,

industry, academia, health service providers, and patients/consumers

• Neutral forum for collaboration and the sharing of information and expertise

• Secretariat based at the Institute of Health Economics (Canada)

7% 3%

16%

74%

Country of origin - income classification

Low income

Lower middleincome

Upper middleincome

High income

n = 1049

HTAi: The Clinical & Professional HTA Society

Memorandum of

Understanding

Mission:

Support and promote the development, communication, understanding and use

of HTA around the world as a scientifically-based means of promoting the

introduction of effective innovations and the effective use of resources in health

care

Health Technology Assessment

International (HTAi)

Board Executive Committee

President Guy Maddern, Australia

Vice President Sean Tunis, USA

Treasurer Don Juzwishin, Canada

Secretary Americo Cicchetti, Italy

Board Directors Jeonghoon Ahn, South Korea Katrine Frønsdal, Norway David Grainger, Australia Rabia Kahveci, Turkey Deborah Marshall, Canada François Meyer, France Alric Rüther, Germany

HTAi a neutral and transparent society

• Code of conduct

• Conflict of interest

• Influence from sponsors and

their relation with society’s

activities

Policy in place regarding conflict of interest

There is…: AM guidelines

Sponsorship.

• With the exception of satellite symposia, organizations will typically not be permitted to sponsor specific scientific sessions during the Annual Meeting. Organizations sponsoring sessions of any kind must not display promotional materials (e.g., signage with organizational logos) within the session room. However, sponsors’ logos may appear on Annual Meeting programs, promotional brochures, “give‐away” items, and signage displayed in hallways of the Annual Meeting venue.

Policy in place (ii)

• Under no circumstances may

sponsors be permitted to

exercise influence over the

scientific content of the Annual

Meeting, with the exception of

submitting session proposals

for consideration by the ISPC.

Not just this but…

HTAi statement on relations with public and private organizations

1.HTAi is a scientific and professional membership society. It welcomes organizational members and sponsors whose support helps to further the mission of the Society, particularly through the development of new initiatives and the extension of activities to less developed countries.

2.HTAi recognises that all organisations (governments, non-governmental organisations and businesses) have interests. HTAi protects its integrity and independence by requiring transparency in all financial support, by relying primarily on individual members for core funding and by having a diversified pool of sponsors so that no single interest has undue importance.

Not just this but…

• For meeting sponsorship, HTAi welcomes contributions in support of an event as a whole, and such contributions will be given appropriate acknowledgement in programmes, posters and other promotional material. Sessions in main meeting programmes are run under the standards of scientific and professional peer review and these sessions may not be sponsored by an outside organisation. Social events, pre- and post-meeting workshops and other elements (e.g., bags, books, etc.) may be sponsored at the discretion of the Board. Those participating in HTAi meetings are personally responsible for the costs to them of registration and attendance. HTAi willingly invites organisations to sponsor participants’ attendance at meetings by subsidising the costs to participants of registration, travel and accommodation, particularly for students and for those attending from less developed countries.

• HTAi adheres to the principles on conflicts of interest promulgated by the International Committee of Medical Journal Editors. All those invited or offering to submit contributions to sessions or posters in main meeting programmes are obliged to declare sources of support and potential conflicts of interest as a regular part of the review process.

• All HTAi Board members are required to declare any interests which might conflict or be seen to conflict with their work for the Society.HTAi supports integrity and transparency by inviting all members and other interested parties to view these declarations and its financial statements. .

What is technology?

«the systematic application of

scientific and other organized

knowledge to practical tasks»

Galbraith, J. K. (1967).

The new industrial state.

Boston, MA: Houghton Mifflin.

Technology?

«When we talk about technology, we

do not only refer to devices or

machines, but the way we address

and resolve problems.»

“It is the knowledge of how to

combine resources to produce

desired products, to solve problems,

fulfill needs, or satisfy wants; it

includes technical methods, skills,

processes, techniques, tools and raw

materials”.

Health technology

“Any intervention that can be used to promote health, to prevent, diagnose or treat a disease or for rehabilitation or long term care. This includes pharmaceuticals, medical devices, procedures and organizational systems used in health care.”

OTA, 1978

Health Technology Assessment

• [HTA] is a multidisciplinary field of policy analysis. It studies the

medical, social, ethical, and economic implications of

development, diffusion, and use of health technology

(International Network of Agencies for Health Technology Assessment 2002).

HTA and how it is seen

"To infinity and beyond!"

HTA is much more than health economics

HTA is mainly a retrospective assessment approach

Use o

f t

echnolo

gy in h

ealt

h c

are

Time line of research -innovation - technology

Experi-mental

Investiga-tional

Nearly established Established

Technology Basic research

Applied research

Technologies of low added value.

Obsolete?

HTA

Healt

h N

eed

s

Assessm

ent

?

Proactive HTA? EAA

Disinvestment

From regulation to coverage R

egu

lati

on

Safety and efficacy

Evid

ence

Bas

ed h

ealt

h c

are

Effectiveness

Co

mp

arat

ive

effe

ctiv

enes

s

Comparison of effectiveness among different technologies

HTA

Organizational, economic, legal social/cultural, political, ethical

+ + +

Can it work? Does it work? Does it work proper than

others? Is it worth it?

Market authorization

Prescription Provision Coverage

reimbursement decisions

Clinical research

Health Services Related

Assessment

Appropriate use

Innovation

Preclinical Research

RD+i

Regulation Market authorisation

Investment Health provision

Disinvestment Exclusion from provision

Research & development Early dialogue

HTA reports Including ELSOI and economic

analysis

Clinical Practice Guidelines

and

Post-introduction HTA

reassessments

Clinical trials and other

epidemiological designs

Proofs of concept

Technology

feasibility reports

Evidence based life

cycle information

Health Impact Assessment

Health Technology Assessment

Health Technology

Management

Health Needs Aassessment

Need for context...

• Evidence – Physical

– Economic

– Biological

• Values – Ethics

– Law

• Organization – Social

– Cultural

– Health system

Context

Portfolio of activities

• Annual meetings

• Policy fora

• Interest subgroups

• Other meetings (Regional, Regional PF)

• IJTAHC

• International Collaborations

• Grants and scholarships

• Online resources

Major Activities

• HTAi Annual Meetings : the key global venue for sharing advances in

research, policy, methods

– 2010: “Maximizing the value of HTA,” Dublin, Ireland

– 2011: “HTA for Health System Sustainability,” Rio de Janeiro, Brazil

– 2012: “HTA for integrated care in a patient-centered system,” Bilbao (Basque Country),

Spain

– 2013: Seoul, Korea, Values

• 2014 HTAi Washington. Optimizing Patient-Centered Care in an era of Economic

Uncertainty

• 2015 Oslo, Norway: Global Efforts in Knowledge Transfer: HTA to Health Policy &

Practice

• 2016 Tokyo, Japan: Informing health care decisions with values and evidence

HTAi Policy Forum

• A venue for senior leaders from the public and private sectors to hold

strategic discussions informed by the perspectives of their different

organizations

• Meets twice annually; meetings held under the Chatham House Rule

• Summary of discussions published in the International Journal of Technology

Assessment in Health Care

• Recent topics: Evidence production, Adaptive licensing, HTA and

Disinvestment, HTA-Regulatory Interactions, Managed Entry Agreements,

HTA for Optimization of Health Technology Use, Coverage with Evidence

Development, Harmonization of HTA

Papers of the HTAi Policy Forum

• Published in International Journal of Technology Assessment in Health Care; free

access at http://www.htai.org 2015 Background paper - "Improving the effectiveness and efficiency of evidence production for HTA in the light of

current trends in drug and device development, health system funding, regulation and HTA“ K. Facey on behalf of

the HTAi Policy Forum

"Adaptive Approaches to Licensing, Health Technology Assessment, and Introduction of Drugs and Devices"

D. Husereau, C. Henshall & J. Jivraj on behalf of the HTAi Policy Forum

"Using Health Technology Assessment to Support Optimal Use of Technologies in Current Practice: The

Challenge of "Disinvestment"" (deliberations from the 2012 meeting)

Interactions between HTA, coverage, and regulatory processes: emerging issues, goals, and opportunities

(deliberations of 2011 forum)

What principles should govern the use of managed entry agreements? (deliberations of 2010 forum)

HTA to optimize health technology utilization: using implementation initiatives and monitoring processes

(deliberations of 2009 forum)

Harmonization of evidence requirements in HTA for reimbursement decision-making (deliberations of 2008 forum)

Interest Groups

Eleven Interest Groups serve as hubs for sharing international

experiences and expertise among HTA users and producers

worldwide:

• Conditional Coverage/Access with Evidence Development

• Disinvestment • Ethical Issues in HTA • Hospital-based HTA • HTA-Regulatory Interactions

• HTA in Developing Countries • Early Career Network • Information Resources • Patient and Citizen Involvement • Initiatives on Public Health

Interventions (INPHORM) • Vaccines

Major Activities • Other national, regional, and international meetings and symposia

• HTAi Latin American Regional meeting 2016 (in collaboration with PAHO, REDETSA,

Ministry for Health Costla Rica)

• HTAi Asia Policy Forum. Singapur 2015

• HTAi Latin American Regional Meeting, November 2014 (in collaboration with PAHO,

REDETSA, CENETEC)

• HTAi Asia Policy Forum. Korea 2013

• HTAi Latin American Regional Meeting, November 2012 (in collaboration with PAHO,

World Bank, Ministries of Health)

• HTAi Latin American Regional Meeting, October 2010 (in collaboration with PAHO,

Ministries of Health, industry partners)

• Workshop for regulatory and HTA agency heads, co-organized by HTAi and regulatory

bodies, October 2010

• Symposia at relevant region-wide meetings of other societies (Society for Medical

Decision Making, International Society for Quality in Health Care)

• Workshop on HTA implementation for the Ministry of Health in China

Major Activities

• International Journal of Technology Assessment in

Health Care

• International collaboration. Partnership

• Grants and scholarships

• Online resources

– HTA Glossary, Vortal, newsletters, bulletins

Journal

The International Journal of

Technology Assessment in Health

Care (IJTAHC), published online

quarterly by Cambridge University

Press, is the official journal of HTAi

IF: 1.03

Partnerships

WHO HTAi is a non-governmental organization in official relations with the WHO

INAHTA Partner, MoU

Euroscan Partner, MoU

ISQua Partner, MoU

HTAi also collaborates with over 75 organizational members

and regularly works with other like-minded organizations,

societies to further promote/support HTA

Grants and scholarships

• HTAi offers scholarships and travel grants to support

individuals working in HTA in low and middle income countries:

– HTAi Educational Scholarships

To benefit individuals from developing countries studying HTA

– The Jill Sanders Memorial Scholarship

To benefit individuals from Africa studying HTA

– HTAi Travel Grants

To support individuals from low and middle income countries and to

support representatives from non-profit patient organizations to attend

HTAi Annual Meetings

•

HTA Glossary

• The HTA glossary is an official

collaboration between International

Network of Agencies for Health

Technology Assessment (INAHTA),

Health Technology Assessment

international (HTAi) and other

partner organizations (EuroScan,

ISQuA,…).

History of HTA Glossary

• 2002 INAHTA meeting: members discussed the need for a list of standard definitions of terms used in health technology

assessment

• March 2004: First draft circulated to all INAHTA members

• Fall 2004: aggregation with glossary developed by Cliff Goodman for the course TA 101 of the US National Library of

Medicine

• 2006 INAHTA meeting: Start of development of the French language version coordinated by CEDIT, continued by AETMIS

• 2007 Avalia-T Start of development of the Spanish language version coordinated by AVILA-T

• 2005-2010 Glossary under the responsibility of the INAHTA working group Education and Training

• 2010 Approval of the ToR of Glossary Steering Committee by boards of INAHTA and HTAi

• 2011 Start of Steering Committee work with numerous partner organisations

• International collaborative work through Wikibased website

• Divisions of 500+ terms into 13 fields (health economics, biostatistics, …)

• English, French and Spanish (coming versions German and Portuguese)

• ISO norms 704,860,10241, 1087-1 to be implemented

• Linkage with established technical terminologies (such as the Canadian Termium

database)

http://www.htaglossary.net/

Composition of Steering Committee

• Board of HTAi representative and Chair: Tracy Merlin, Australia

• Board of INAHTA representative: Wendy Babidge, Australia

• European network for Health Technology Assessment (EUnetHTA): Patrice Chalon, Belgium

• Canadian Bureau of translation: Sylvie Bouchard, Canada

• International Information Network on New and Emerging Health Technologies (EuroScan): Iñaki Gutierrez-Ibarluzea, Spain

• Cochrane Collaboration: Sally Green, Australia

• International Society for Quality in Health Care (ISQua): Wendy Nicklin, Canada

• Guidelines International Network (G-I-N): Minna Kaila, Finland

• English Editorial Board: TBD

• Spanish Editorial Board: Leonor Varela Lema, Spain

• French Editorial Board: Marie-Josée Pelletier, Canada

HTAi vortal

HTAi newsletter

36

Upcoming Activities: Highlights

• WHO General Assembly and Medical Devices Meeting

• HTA promotion in Asia-Pacific:

– Fourth edition of the Asian PF

• HTA promotion in LAC

• Fourth edition of the LAC regional meeting in collaboration with REDETSA

• Second Latin American Policy Forum. Lima. Perú

• New activities of the Interest Groups

• Upcoming Policy Forum discussions

Big Hits

• WHO resolution on Universal

Health Coverage and the role

of HTA

• HTAi is the unique HTA society

that deserves consideration of

WHO as member of the WHA

since 2014.

Join us

• Do you want to meet and contact high profile decision makers (clinicians, patients, managers, politicians,…) within the HTA and Health Outcomes research arena?

• Would it be cost & time effective to meet multiple prospects in one setting over three days? HTAi meeting Tokyo

• Do you want a fast track to gaining competitive advantage and increased discussion share?

• If your answer is yes to any of these questions, you should be participating in this society and positioning yourself as thought leaders in the HTA space.

39

HTAi Rome 2017

Explore How The Global HTA Community Is

Evolving Towards An Integrated Ecosystem

Join us for HTAi’s 14th Annual Meeting on June

17-21, 2017 at the Ergife Palace Hotel in Rome,

Italy. HTAi welcomes those invested in the

production and implementation of HTA from

Italy, neighbouring countries and around the

world.

Plenaries Confirmed Speakers Workshops

Play Video

Register Now & Save

Early Bird Deadline Extended: March 31, 2017

Plennary sesssions. June 19: Towards An Integrated HTA

Framework For A More Sustainable Health Care Ecosystem

Key note Speaker

• Dr. Wim Goettsch, Director EUnetHTA JA3 Directorate, National Health Care Institute (ZIN), The Netherlands

Panelists

• Dr. Erik Normann, President, International Hospital Federation, Norway

• Dr. Brian O'Rourke, President and CEO, Canadian Agency for Drugs and Technologies in Health, Canada

• Prof. Ina Kopp, Director, Institute for Medical Knowledge Management, Association of the Scientific Medical Societies (AMWF), Germany

• Dr. Nguyen Khanh Phuong, Head of Health Economic Department, Health Strategy and Policy Institute, President, HTAsiaLink, Vietnam

Principles and the way forward

• Co-chairs

Dr. Rabia Kahveci, Head of HTA Unit at Ankara Numune Training and Research Hospital (ANHTA), Turkey

Dr. Alric Ruether, Head International Affairs, Institute for Quality and Efficiency in Health Care (IQWiG), Germany

Plennary sesssions. June 20: Embracing A Value-

based Paradigm In Health Care Systems

Speakers:

• Prof. Gualtiero Ricciardi, President, Istituto Superiore di Sanità, Italy

• Prof. Christopher Chute, Bloomberg Distinguished Professor, Department of Health Policy and Management, The Johns Hopkins Institute for Clinical and Translational Research, USA

• Dr. Merran Smith, Chief Executive, Population Health Research Network, Australia

• Dr. Michael Seewald, VP & Worldwide Head, Center of Excellence for Real World Evidence, Novartis Pharma, Switzerland

Engaging Professionals And Mastering Big Data For Effective HTA

Co-chairs

• Prof. Americo Cicchetti, Professor of Management, Faculty of Economics, Catholic University of the Sacred Heart, Italy Dr. Wija Oortwijn, Manager Health Unit, Ecorys Nederland B.V., The Netherlands

Plennary sesssions June 21: Facing Ethical

Dilemmas For A Health System’s Sustainability

Speaker

• Prof. Norman Daniels, Mary B. Saltonstall Professor of Population Ethics and Professor of Ethics and Population Health Department of Global Health and Population, Harvard School of Public Health, USA

Panelist

• Prof. Antonio Gasbarrini, Director of Internal Medicine, Fondazione Policlinico "A. Gemelli", Italy

• Jolanta Bilinska, Chair, International Alliance of Patients' Organizations, Poland

• Alexandre Lemgruber, Regional Advisor - Health Technologies, PAHO - Pan American Health Organization, Brazil

The Role Of Multi-stakeholder Involvement In HTA

• Co-chairs:

Eleanor Bradford, Head of Communications, University of Aberdeen, UK Dr. Sean Tunis, Founder & Chief Executive Officer, Center for Medical Technology Policy (CMTP), USA

More Information

HTAiOrg

HTAi.org

Lucy Turner, Managing Director

lturner@htai.org